Solutions for SARS-CoV-2 Detection

SARS-CoV-2 Detection

We are here to help laboratories overcome their SARS-CoV-2 testing challenges so they can better address the world’s urgent public health concerns. We are working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and vaccine development solutions they need to rapidly respond to these challenges. Our top priority is to provide the technology and support to meet these needs.


Explore our SARS-CoV-2 Testing Products

PerkinElmer® COVID-19 Antigen Test

PerkinElmer® COVID-19 Antigen Test

Enable your POC testing with the PerkinElmer® COVID-19 Antigen Test, a simple, rapid, and reliable lateral flow immunoassay test used to screen or diagnose asymptomatic or symptomatic individuals for COVID-19.

Learn More

Simultaneous COVID-19, Flu, and RSV Test

Simultaneous COVID-19, Flu, and RSV Test

Detect and differentiate SARS-CoV-2, influenza A, influenza B, and RSV in a single sample with the CE-IVD marked PKamp Respiratory SARS-CoV-2 RT-PCR Panel. This workflow enables labs to conserve resources while testing a single sample for multiple pathogens.

Learn More

PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit CE-IVD

PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit CE-IVD

The PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit delivers qualitative detection of human IgG antibodies against SARS-CoV-2 in dried blood spots (DBS), plasma, and serum to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Automated, high-throughput processing of DBS is available with the GSP® instrument.

Manual processing of plasma and serum samples is available with the VICTOR2 D instrument.

Learn More

Remote Services

Remote Services

Resolve instrument repairs faster and increase uptime. OneSource remote options do just that. Remote Support and Radian Remote Diagnostic services.

Learn More

Maximize Your SARS-COV-2 Testing Efficiency

Maximize Your SARS-COV-2 Testing Efficiency

PerkinElmer offers complete workflow solutions including reagents, instrumentation, and consumables for the detection of SARS-CoV-2 RNA and the screening for SARS-CoV-2 antibodies. With the ability to process up to 10,000 samples/day, the scalable and modular explorer™ automated workstations along with a reliable supply of PerkinElmer’s reagents and consumables can maximize the efficiency of your SARS-CoV-2 testing 24/7.

Learn More

Webinar

News Stories


The Future of COVID Testing

Prahlad Singh, President and CEO of PerkinElmer, sat down with This Week in Business on NECN to talk about the Company’s COVID-19 RT-PCR and antigen tests, and how he perceives the COVID-19 testing landscape to be as vaccines roll out.

Read More

Blog Posts



Coronalab.eu Travel Clinic

Coronalab.eu Travel Clinic

Read our blog post to learn about CoronaLab, a business unit of Microbe&Lab B.V., which provides cutting-edge SARS-CoV-2 RT-PCR testing for non-symptomatic people.

Read More








Navigating the FDA’s EUA Process for Diagnostics

Navigating the FDA’s EUA Process for Diagnostics

Dr. Elizabeth Hillebrenner, associate director for scientific and regulatory programs at the FDA’s Center for Devices and Radiological Health, kicked off this virtual roundtable with an overview of the EUA program, how it evolved, and how lessons learned during the current pandemic may shape future policies and actions by the FDA. She then took part in a panel discussion that included a variety of stakeholders from the diagnostics and clinical lab industries.

Read More




Anterior Nasal Swabs for COVID-19 Testing

Anterior Nasal Swabs for COVID-19 Testing

The FDA has authorized a new sample type, anterior nasal swabs, for use with some EUA authorized real-time RT-PCE assays for COVID-19 testing. Using anterior nasal swabs for SARS-CoV-2 testing offers many advantages over the typical sample types, human oropharyngeal and nasopharyngeal swab samples.

Read More






Importance of Immunoassays for Coronavirus Control

Importance of Immunoassays for Coronavirus Control

On December 31, 2019, a pneumonia case in the Chinese city, Wuhan, with unknown pathological origin, was reported into the Chinese World Health Organization (WHO) office. By March 11, 2020, the virus had spread to 114 countries and had taken nearly 4,300 lives leading WHO to declare COVID-19 a global pandemic (WHO, 2020).

Read More







How to Handle Inconclusive Samples with SARS-CoV-2 Real-Time PCR Tests

How to Handle Inconclusive Samples with SARS-CoV-2 Real-Time PCR Tests

SARS-CoV-2 real-time reverse transcription polymerase chain reaction (RT-PCR) tests, can be inaccurate in two ways, as can all diagnostic assays. A false-positive result mistakenly identifies a person as infected, resulting in unnecessary quarantine and contact tracing. False-negative results are far more problematic because infected people may not isolate themselves and can infect others.






Choosing a SARS-CoV-2 Real-Time RT-PCR Assay

Choosing a SARS-CoV-2 Real-Time RT-PCR Assay

Accurate detection of SARS-CoV-2 is critical for both patient treatments, as well as control of the COVID-19 pandemic. Many factors need to be considered when choosing a workflow to use for SARS-CoV-2 detection.

Read More







Ensuring the Accuracy of your SARS-CoV-2 Testing Results

Ensuring the Accuracy of your SARS-CoV-2 Testing Results

Accuracy of SARS-CoV-2 testing is critical when determining if someone is infected and needs to be quarantined and/or treated for a coronavirus infection. Real-time reverse transcription polymerase chain reaction (RT-PCR) assays are the tool of choice for determining if someone has an active viral shedding of SARS-CoV-2. RT-PCR assays reverse transcribe the viral RNA into DNA for amplification and subsequent identification of target regions.

Read More




Significance & Difference between Target Regions for SARS-CoV-2 Testing

Significance & Difference between Target Regions for SARS-CoV-2 Testing

Severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, the virus responsible for the disease known as COVID-19, is now a global pandemic.  This novel coronavirus was first observed in humans in December of 2019 and sequenced by multiple teams over the next month (Wu et al., 2020; Zhu et al., 2020; Chan et al., 2020).

Read More






Accelerate Your SARS-COV-2 Testing